Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002549

President and CEO gave up 7,484 shares (to pay taxes)

  • President and CEO acquired 25,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Luly Jay R. President and CEO 2025-02-12 Grant or award +25,500 872,138 D: show line 1 in the form
Luly Jay R. President and CEO 2025-02-12 Shares withheld for taxes −7,484 $5.59 $41,836 864,654 D: show line 2 in the form
Loading xslF345X05/form4.xml…